CD8A and glioblastoma: Indeed, RT/TMZ/PL treatment significantly prolonged overall survival (OS) in the G422TN-GBM model and achieved cure by reshaping pro-inflammatory immune microenvironment, in which M1-like tumor-associated macrophages (TAMs) and CD8+ T cells were increased depending on ROS accumulation.